ESSENTIAL HYPERLIPEMIA
Authors: H BENARD, R DUNET, A GAJDOS, H PEQUIGNOT, J POLONOVSKI
Journal: Annals of Internal Medicine (1953)

Article1 April 1953ESSENTIAL HYPERLIPEMIACLAUDE R. JOYNER JR.CLAUDE R. JOYNER JR.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-38-4-759 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn hyperlipemia there exists an increase in the neutral fat fraction of the blood lipids. When this increase is of sufficient degree the serum assumes a grossly chylous or milky appearance, in contrast to the clear serum noted with an increased blood cholesterol or phospholipid content. Following Thannhauser's1 example, the term "hyperlipemia" is now reserved for this increase in neutral fat, whereas an increase in the two other lipid fractions is designated "hypercholesteremia" or "hyperlecithemia."Physiologic hyperlipemia is seen after the ingestion of fats, with a peak in the fat tolerance curve occurring about three hours after a standard test...Bibliography1. Thannhauser SJ: Serum lipids and their value in diagnosis, New England J. Med. 237: 515, 1950. CrossrefGoogle Scholar2. ManGildea EBEF: The effect of the ingestion of a large amount of fat and of a balanced meal on the blood lipids of normal man, J. Biol. Chem. 99: 61, 1932. CrossrefGoogle Scholar3. PetersMan JPEB: Interrelations of serum lipids in patients with thyroid disease, J. Clin. Investigation 22: 715, 1943. CrossrefMedlineGoogle Scholar4. Speck L: Fall von Lipamie, Arch. d. ver. f. wissensch. Heilk. Leipz. 1: 232, 1865. (Quoted by Thannhauser, S. J.) Google Scholar5. KlatskinGordon GM: Relationship between relapsing pancreatitis and essential hyperlipemia, Am. J. Med. 12: 3, 1952. CrossrefMedlineGoogle Scholar6. ChaikoffEntenmanMontgomery ILCML(a) : The mechanism of action of the anti-fatty liver factor of the pancreas, J. Biol. Chem. 160: 489, 1945. (b) Chaikoff, I. L., Entenman, C., and Montgomery, M. L.: The mechanism of action of the anti-fatty liver factor of the pancreas; a comparison of hydrolyzed and unhydrolyzed casein in the prevention of fatty livers of the completely depancreatized dog maintained with insulin, J. Biol. Chem. 168: 177, 1947. CrossrefMedlineGoogle Scholar7. Thannhauser SJ: Lipidoses: diseases of the cellular lipid metabolism, 1950, Oxford University Press, New York. Google Scholar8. BuergerGrütz MO: Über Hepatosplenomegale lipoidose mit xanthomatosen Veranderungen in Haut und Schleimhaut, Arch. f. Dermat. u. Syph. 166: 542, 1932. CrossrefGoogle Scholar9. Opitz H: Hoch grudige lipamie unklarer genese bei einem 12 jahrigen knaben, Deutsche med. Wchnschr. 61: 88, 1935. CrossrefGoogle Scholar10. HoltAylwardTimbres LEFXHG: Familial lipemia of undetermined origin, J. Clin. Investigation 15: 451, 1936. Google Scholar11. HoltAylwardTimbres LEFXHG: Idiopathic familial lipemia, Bull. Johns Hopkins Hosp. 64: 279, 1939. Google Scholar12. FranklinAvery SMH: Splenomegaly with lipaemia, Proc. Roy. Soc. Med. 30: 711, 1937. CrossrefGoogle Scholar13. BernsteinWilliamsHummelShepherdErickson SSHHFCMLBM: Essential hyperlipemia, J. Pediat. 14: 570, 1939. CrossrefGoogle Scholar14. GoodmanShumanGoodman MHS: Idiopathic lipemia with secondary xanthomatosis, hepatosplenomegaly and lipemia retinalis, J. Pediat. 16: 596, 1940. CrossrefGoogle Scholar15. ChapmanKinney FDTD: Idiopathic lipemia, Am. J. Dis. Child. 62: 1014, 1941. CrossrefGoogle Scholar16. Levy BM: Idiopathic lipemia, J. Pediat. 29: 367, 1946. CrossrefMedlineGoogle Scholar17. Harslöf E: Idiopathic familial hyperlipemia attended with hepatosplenomegaly, Acta med. Scandinav. 130: 140, 1948. CrossrefMedlineGoogle Scholar18. ShoreShrive SCU: A possible case of idiopathic hyperlipemia, Clin. Proc. 6: 138, 1947. MedlineGoogle Scholar19. BloomfieldShenson ALB: The syndrome of idiopathic hyperlipemia with crises of violent abdominal pain, Stanford M. Bull. 5: 185, 1947. MedlineGoogle Scholar20. Hopgood WC: Idiopathic hyperlipemia, New England J. Med. 238: 429, 1948. CrossrefMedlineGoogle Scholar21. KoszalkaLevin MFJJ: Idiopathic hyperlipemia, Ann. Int. Med. 33: 473, 1950. LinkGoogle Scholar22 MovittGerstlSherwoodEpstein ERBFCC: Essential hyperlipemia, Arch. Int. Med. 87: 79, 1951. CrossrefGoogle Scholar23 FrankLevitt LLM: Idiopathic hyperlipemia with secondary xanthomatoses, Arch. Dermat. and Syph. 64: 434, 1951. CrossrefGoogle Scholar24. Hand EA: Guttate xanthomatosis secondary to idiopathic lipemia, Arch. Dermat. and Syph. 63: 522, 1951. Google Scholar25. Lepard CW: Lipemia retinalis in the non-diabetic subject, Arch. Ophth. 32: 37, 1947. CrossrefGoogle Scholar26 Chase LA: Diabetic lipemia retinalis; report of a case, J. A. M. A. 97: 171, 1931. CrossrefGoogle Scholar27. CarfagnoSteiger SCWA: Serum lipids in lipemia retinalis, Am. J. M. Sc. 221: 379, 1951. CrossrefMedlineGoogle Scholar28. AhrensKunkel EHHG: The stabilization of serum lipid emulsions by serum phospholipids, J. Exper. Med. 90: 409, 1949. CrossrefMedlineGoogle Scholar29. ThannhauserReinstein SJH: Fatty changes in the liver from different causes; comparative studies of lipid partition, Arch. Path. 33: 646, 1942. Google Scholar30. HaanesGyörgy MLP: In vitro action of a new lipotropic fraction in the pancreas, Am. J. Physiol. 166: 441, 1951. CrossrefMedlineGoogle Scholar31. Iason AH: Hernia, 1941, The Blakiston Co., Philadelphia. Google Scholar32. Eilert ML: The effect of estrogens upon the partition of the serum lipids in female patients, Am. Heart J. 38: 472, 1949. Google Scholar33. AdlersburgSchaeferDritch DLER: Effect of cortisone, adrenocorticotropic hormone, and desoxycorticosterone acetate on serum lipids, J. Clin. Investigation 29: 795, 1950. Google Scholar34. LevinFarber LRK: Relation of cortisone pretreatment to mobilization of lipids to liver by pituitary extracts, Proc. Soc. Exper. Biol. and Med. 74: 758, 1950. CrossrefMedlineGoogle Scholar35. GertlerGarnLerman MMSMJ: The interrelationships of serum cholesterol, cholesterol esters and phospholipids in health and in coronary artery disease, Circulation 2: 205, 1950. CrossrefMedlineGoogle Scholar36. AhrensKunkel EHHG: The relationship between serum lipids and skin xanthomata in eighteen patients with primary biliary cirrhosis, J. Clin. Investigation 28: 1565, 1949. CrossrefMedlineGoogle Scholar37. Ahrens EH: The lipid disturbance in biliary obstruction and its relationship to the genesis of arteriosclerosis, Bull. New York Acad. Med. 26: 151, 1950. MedlineGoogle Scholar38. Hahn PF: Abolishment of alimentary hyperlipemia following injection of heparin, Science 98: 19-20, 1943. CrossrefMedlineGoogle Scholar39. Weld CB: Alimentary lipemia and heparin, Canad. M. A. J. 51: 578, 1944. Google Scholar40. WaldronFriedman JMMH: The relationships between anticoagulants and lipemia, Federation Proc. 7: 130, 1948. MedlineGoogle Scholar41. AndersonFawcett NGB: An antichylomicronemic substance produced by heparin injection, Proc. Soc. Exper. Biol. and Med. 74: 768, 1950. CrossrefMedlineGoogle Scholar42. Swank RL: Changes in blood produced by a fat meal and by intravenous heparin, Am. J. Physiol. 164: 798, 1951. CrossrefMedlineGoogle Scholar43. BlockMannBarker WJFDNW: Effect of small doses of heparin in increasing the translucence of plasma during alimentary lipemia; studies in normal individuals and patients with atherosclerosis, Proc. Staff Meet., Mayo Clin. 26: 246, 1951. MedlineGoogle Scholar44. Poulsen HM: Familial lipaemia—a new form of lipoidosis showing increase in neutral fats combined with attacks of acute pancreatitis, Acta. med. Scandinav. 138: 413, 1950. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: MC USNR Oakland, California*Received for publication June 6, 1952.From the Medical Service of the United States Naval Hospital, Oakland, California.The opinions expressed are those of the author, and do not necessarily reflect the views of the Medical Department of the Navy or of the Navy Department. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe Assay of Lipoprotein Lipase in Vivo and in VitroEssential HyperlipemiaDigestive SystemExperiences with acute pancreatic inflammatory disease at a small city hospitalThe differential diagnosis of coronary artery disease and gastrointestinal disorders∗Studies on the Clearing Phenomenon in Essential HyperlipemiaKrankheiten der GefäßeSerum Lipids in Acute PancreatitisESSENTIAL HYPERLIPEMIA*B. C. PAYNE, M.D., A. M. WALDRON, M.D., F.A.C.P.Idiopathic Hyperlipaemia, Latent Diabetes Mellitus and Severe NeuropathyThe Genetic Mechanism of Idiopathic HyperlipemiaIdiopathic Hyperlipaemia: Report of a Case Studied with Radioactive Iodine-Labelled FatEssential hyperlipemiaHYPERLIPEMIA ASSOCIATED WITH DIABETES MELLITUS AND PANCREATITIS: A CASE REPORT WITH AUTOPSY*CHARLES R. TOURTELLOTTE, M.D., RUSSELL D. TYLER, M.D.Essential Hyperlipemia Treated with Heparin and with ChlorpromazineOffice Diagnosis and Treatment of Essential HyperlipemiaESSENTIAL HYPERLIPÆMIAKrankheiten des MyokardsEssential Hyperlipaemia 1 April 1953Volume 38, Issue 4Page: 759-777KeywordsBloodCholesterolFatsHypercholesterolemiaHyperlipidemiaIngestionLipidsMedical servicesPhospholipids ePublished: 1 December 2008 Issue Published: 1 April 1953 PDF downloadLoading ...